Our goal is to equip clinicians with advanced computer-assisted tissue analysis for improved surgical precision and patient safety.
Hypervision Surgical has raised €27M across 2 funding rounds from 7 investors, most recently a Series A round in Apr 2026. Based in London, UK; active in Healthtech. Data as of 6 Aug 2026.
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2026-04-30 | Series A | €20M | Angelini Ventures,Heran Partners,LifeX Ventures,Redalpine,SINC Fund managed by SAGES Ingenuity,ZEISS Ventures | View deal → |
| 2023-06-02 | Seed | €7.6M | HERAN Partners,LifeX Ventures,Redalpine,ZEISS Ventures | View deal → |
